This pilot study followed 9 patients diagnosed with Rheumatoid Arthritis who each received 30 hyperbaric oxygen treatments over six to 10 weeks. Follow up MRI scans at both 3 months and at 6 months showed beneficial response to this procedure. These findings support an earlier pilot study that documented improvement in "disease activity and joint pain as determined by multiple, validated clinical measures".  The findings of this study suggest that "hyperbaric oxygen therapy  may be useful as an adjunctive or alternative treatment to disease-modifying drugs for rheumatoid arthritis" <view study> Read Less

COVID-19 brings along an ever-growing concern for infected patients who have recovered from the acute phase of the viral infection. These individuals are now suffering from the long-term adverse health effects as a result. These long-term complications (aka long COVID-19), have been shown to affect everyone; including the chronically-sick, the healthy, and even the professional athlete. “Long COVID-19 patients show systemic inflammation and persistent symptoms such as fatigue and malaise, profoundly affecting their quality of life” Hyperbaric oxygen therapy (HBOT) has been shown to help the body produce a strong anti-inflammatory response that may be able to help combat Long Covid and provide symptomatic relief. This study evaluated 5 subjects, (2 patients and 3 athletes) undergoing HBOT for 30 sessions and all 5 showed attenuation of inflammatory biomarkers, particularity the 2 athletes. “From this preliminary observation, HBOT could be considered a potential treatment for long COVID-19 patients.” <view study> Read Less

Resistive thin endometrium can cause many complications during pregnancy including miscarriages along with lower pregnancy rates in fertility treatments like IVF. Frozen Embryo Transfer (FET) is another fertility treatment that has less favorable outcomes with thin endometrium. There have been reports that hyperbaric oxygen therapy can effectively increase endometrial thickness and thus help support the pregnancy process. Researchers in this study gave a simple course of daily hyperbaric oxygen sessions at 2.5 ATA for 10 days. This was done prior to endometrial transformation for FET and led to a significantly thicker endometrial thickness on the day of the endometrium transformation <view study>   Read Less

A new landmark study in hyperabric medicine (HBOT) shows that breathing air (21% oxygen) at 1.3 ATA of hyperbaric pressure mobilizes stem cells! Since 2006, it became clear to us that HBOT helps the body to accelerate tissue repair and regeneration by stimulating the release of stem cells in the bone marrow What we did not know is at what pressure level this occurs at. So a team of researchers decided to try and find out and they published their results in this study. They found that a minimal pressure level of 1.3 ATA caused a significant elevation in stem cells. Moreover, the researches did not add extra oxygen into a breathing apparatus, so the results were purely based upon pressure-alone. This landmark study clearly demonstrates that pressure-alone can be a contributing factor to some of the remarkable benefits that have been documented with hyperabric oxygen therapy. More importantly, it shows that these potentially-contributing  benefits can be achieved at lower pressures and without the use of supplemental oxygen. <view study> Read Less

Lymphedema is a common complication following treatment for breast cancer, which negatively affects quality of life (QOL). This study looked at 19 women who presented with lymphedema 1 year after breast cancer treatment and offered them 40 sessions of hyperbaric oxygen therapy over a 2 month period of time. They then followed up with these women 6 months later to evaluate any changes in quality of life. The results were promising and the participants reported significant improvements in QOL. These improvement included; physical functioning, fatigue, insomnia and breast and arm symptoms. with improvements peaking at 6-month follow-up <view study> Read Less